Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Surgically Unresectable Liposarcoma”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT01506596
What this trial is testing

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

Who this might be right for
LiposarcomaSurgically Unresectable LiposarcomaMetastatic Liposarcoma
Vector Oncology 42
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT00400569
What this trial is testing

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Who this might be right for
LiposarcomaLeiomyosarcomaFibrosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT02249949
What this trial is testing

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Who this might be right for
Liposarcoma
Alliance for Clinical Trials in Oncology 15
Testing effectiveness (Phase 2)Study completedNCT02500797
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Ended earlyNCT03074318
What this trial is testing

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic LeiomyosarcomaMetastatic LiposarcomaUnresectable Leiomyosarcoma+1 more
Fred Hutchinson Cancer Center 35